The Academic Center for Education, Culture and Research (ACECR) is an Iranian public non-governmental higher education institution established in 1980.


ACECR engages in innovative research and development projects in different fields of science and technology and real-world applications; for example in 2015 researchers led by Keyvan Majidzadeh produced a new formulation of anti-breast cancer drug Herceptin using a bacterial method.[1] Its activities can be broadly divided into the areas of: research and technology, education, cultural activities, and entrepreneurship.


Only 20% of ACECR’s funding comes from public sources, while the majority of its funding is derived from partnerships and cooperation with the private sector.[2]


ACECR has 680 full-time research and academic staff, and 1,600 full-time research assistants.[2] Its activities are supported by 2,100 services and administrative staff. Industry experts and post graduate research students also contribute to projects on a part-time basis.